HDAC10 expression is associated with DNA mismatch repair gene and is a predictor of good prognosis in colon carcinoma

Tao,Xiangxiang; Yan,Yifeng; Lu,Linming; Chen,Bing

doi:10.3892/ol.2017.6818

HDAC10 expression is associated with DNA mismatch repair gene and is a predictor of good prognosis in colon carcinoma

Authors:
- Xiangxiang Tao
- Yifeng Yan
- Linming Lu
- Bing Chen
View Affiliations

Affiliations: Department of Pathology, Wannan Medical College, Wuhu, Anhui 241001, P.R. China, Department of Forensic Pathology, Wannan Medical College, Wuhu, Anhui 241001, P.R. China
Published online on: August 24, 2017 https://doi.org/10.3892/ol.2017.6818
Pages: 4923-4929

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Despite increasing evidence of the involvement of histone deacetylase (HDAC)10 in cancer tumorigenesis, the potential role of HDAC10 in colon cancer remains unclear. Oncomine database analysis revealed that HDAC10 mRNA was significantly upregulated in colon cancer. In an independent cohort, consistent with mRNA expression levels, constitutively high HDAC10 expression was observed in the cytoplasm and nucleus compared with in adjacent normal tissues (cytoplasm, 93.12±12.98 vs. 31.65±26.50%; nucleus, 84.16±19.23 vs. 68.64±19.00%). Cytoplasmic HDAC expression correlated with gender (r=0.265; P<0.05), lymph node metastasis (N stage; r=0.256; P<0.05) and distant metastasis (M stage; r=0.331; P<0.05) in paracarcinoma tissues. Cytoplasmic HDAC10 expression in tumors was not associated with the four DNA mismatch repair genes examined, but was negatively correlated with mutL homolog 1 (MLH1) (r=‑0.244; P<0.05), mutS homolog (MSH)2 (r=‑0.410; P<0.01) and MSH6 (r=‑0.240; P<0.05) in paracarcinoma tissues. Similarly, nuclear HDAC10 expression was negatively correlated with MLH1 expression (r=‑0.288; P<0.05). The findings of the current study suggest that HDAC10 expression is associated with good prognosis in colon cancer tissues and poor prognosis in paracarcinoma tissues with a potential involvement in DNA mismatch repair.

View Figures

View References

1	Yuan Z, Peng L, Radhakrishnan R and Seto E: Histone deacetylase 9 (HDAC9) regulates the functions of the ATDC (TRIM29) protein. J Biol Chem. 285:39329–39338. 2010. View Article : Google Scholar : PubMed/NCBI
2	Clocchiatti A, Florean C and Brancolini C: Class IIa HDACs: From important roles in differentiation to possible implications in tumourigenesis. J Cell Mol Med. 15:1833–1846. 2011. View Article : Google Scholar : PubMed/NCBI
3	Kotian S, Liyanarachchi S, Zelent A and Parvin JD: Histone deacetylases 9 and 10 are required for homologous recombination. J Biol Chem. 286:7722–7726. 2011. View Article : Google Scholar : PubMed/NCBI
4	Lai IL, Lin TP, Yao YL, Lin CY, Hsieh MJ and Yang WM: Histone deacetylase 10 relieves repression on the melanogenic program by maintaining the deacetylation status of repressors. J Biol Chem. 285:7187–7196. 2010. View Article : Google Scholar : PubMed/NCBI
5	Oehme I, Lodrini M, Brady NR and Witt O: Histone deacetylase 10-promoted autophagy as a druggable point of interference to improve the treatment response of advanced neuroblastomas. Autophagy. 9:2163–2165. 2013. View Article : Google Scholar : PubMed/NCBI
6	Oehme I, Linke JP, Böck BC, Milde T, Lodrini M, Hartenstein B, Wiegand I, Eckert C, Roth W, Kool M, et al: Histone deacetylase 10 promotes autophagy-mediated cell survival. Proc Natl Acad Sci USA. 110:E2592–E2601. 2013. View Article : Google Scholar : PubMed/NCBI
7	Pinto G, Shtaif B, Phillip M and Gat-Yablonski G: Growth attenuation is associated with histone deacetylase 10-induced autophagy in the liver. J Nutr Biochem. 27:171–180. 2016. View Article : Google Scholar : PubMed/NCBI
8	Li Y, Peng L and Seto E: Histone deacetylase 10 regulates the cell cycle G2/M phase transition via a novel let-7-HMGA2-cyclin A2 pathway. Mol Cell Biol. 35:3547–3565. 2015. View Article : Google Scholar : PubMed/NCBI
9	Radhakrishnan R, Li Y, Xiang S, Yuan F, Yuan Z, Telles E, Fang J, Coppola D, Shibata D, Lane WS, et al: Histone deacetylase 10 regulates DNA mismatch repair and may involve the deacetylation of MutS homolog 2. J Biol Chem. 290:22795–22804. 2015. View Article : Google Scholar : PubMed/NCBI
10	Osada H, Tatematsu Y, Saito H, Yatabe Y, Mitsudomi T and Takahashi T: Reduced expression of class II histone deacetylase genes is associated with poor prognosis in lung cancer patients. Int J Cancer. 112:26–32. 2004. View Article : Google Scholar : PubMed/NCBI
11	Park BL, Kim YJ, Cheong HS, Lee SO, Han CS, Yoon JH, Park JH, Chang HS, Park CS, Lee HS and Shin HD: HDAC10 promoter polymorphism associated with development of HCC among chronic HBV patients. Biochem Biophys Res Commun. 363:776–781. 2007. View Article : Google Scholar : PubMed/NCBI
12	Lee JH, Jeong EG, Choi MC, Kim SH, Park JH, Song SH, Park J, Bang YJ and Kim TY: Inhibition of histone deacetylase 10 induces thioredoxin-interacting protein and causes accumulation of reactive oxygen species in SNU-620 human gastric cancer cells. Mol Cells. 30:107–112. 2010. View Article : Google Scholar : PubMed/NCBI
13	Fan W, Huang J and Xiao H: Histone deacetylase 10 suppresses proliferation and invasion by inhibiting the phosphorylation of β-catenin and serves as an independent prognostic factor for human clear cell renal cell carcinoma. Int J Clin Exp Med. 8:3734–3742. 2015.PubMed/NCBI
14	Powers J, Lienlaf M, Perez-Villarroel P, Deng S, Knox T, Villagra A and Sahakian E: Expression and function of histone deacetylase 10 (HDAC10) in B cell malignancies. Methods Mol Biol. 1436:129–145. 2016. View Article : Google Scholar : PubMed/NCBI
15	Yang Y, Huang Y, Wang Z, Wang HT, Duan B, Ye D, Wang C, Jing R, Leng Y, Xi J, et al: HDAC10 promotes lung cancer proliferation via AKT phosphorylation. Oncotarget. 7:59388–59401. 2016. View Article : Google Scholar : PubMed/NCBI
16	Islam MM, Banerjee T, Packard CZ, Kotian S, Selvendiran K, Cohn DE and Parvin JD: HDAC10 as a potential therapeutic target in ovarian cancer. Gynecol Oncol. 144:613–620. 2017. View Article : Google Scholar : PubMed/NCBI
17	Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China, 2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
18	Wang X, Liu J, Zhen J, Zhang C, Wan Q, Liu G, Wei X, Zhang Y, Wang Z, Han H, et al: Histone deacetylase 4 selectively contributes to podocyte injury in diabetic nephropathy. Kidney Int. 86:712–725. 2014. View Article : Google Scholar : PubMed/NCBI
19	Song C, Zhu S, Wu C and Kang J: Histone deacetylase (HDAC) 10 suppresses cervical cancer metastasis through inhibition of matrix metalloproteinase (MMP) 2 and 9 expression. J Biol Chem. 288:28021–28033. 2013. View Article : Google Scholar : PubMed/NCBI
20	Jin Z, Jiang W, Jiao F, Guo Z, Hu H and Wang L and Wang L: Decreased expression of histone deacetylase 10 predicts poor prognosis of gastric cancer patients. Int J Clin Exp Pathol. 7:5872–5879. 2014.PubMed/NCBI
21	Petrelli F, Tomasello G, Borgonovo K, Ghidini M, Turati L, Dallera P, Passalacqua R, Sgroi G and Barni S: Prognostic survival associated with left-sided vs right-sided colon cancer: A systematic review and meta-analysis. JAMA Oncol. Oct 27–2016.(Epub ahead of print).
22	Bauer KM, Hummon AB and Buechler S: Right-side and left-side colon cancer follow different pathways to relapse. Mol Carcinog. 51:411–421. 2012. View Article : Google Scholar : PubMed/NCBI